Page last updated: 2024-08-22

ruthenium and Carcinoma

ruthenium has been researched along with Carcinoma in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's5 (45.45)18.2507
2000's1 (9.09)29.6817
2010's1 (9.09)24.3611
2020's3 (27.27)2.80

Authors

AuthorsStudies
Dürst, M; Görls, H; Häfner, N; Hildebrandt, J; Kritsch, D; Runnebaum, IB; Weigand, W1
Das, U; P K, A; Paira, P; Roy, N; Sahoo, SK; Varddhan, S1
Batista, AA; Cerqueira, IH; Costa, AR; de Araujo-Neto, JH; De Grandis, RA; Demidoff, FC; Guedes, APM; Marques, WG; Moraes, CAF; Netto, CD; Pavan, FR; Resende, FA; Sampaio, NZ1
Bergamo, A; Habtemariam, A; Masi, A; Peacock, AF; Sadler, PJ; Sava, G1
ALTSHULER, B; DANIELS, M; HARLEY, JH; KUSCHNER, M; LASKIN, S; NELSON, N1
Berger, W; Heffeter, P; Jakupec, MA; Kapitza, S; Keppler, BK; Lackinger, L; Marian, B; Pongratz, M1
Alessio, E; Bergamo, A; Capozzi, I; Cocchietto, M; Mestroni, G; Sava, G1
Alessio, E; Capozzi, I; Clerici, K; Gagliardi, G; Mestroni, G; Sava, G1
Berdel, WE; Keppler, BK; Kreuser, ED; Piest, A; Thiel, E1
Berger, MR; Keppler, BK; Seelig, MH1
Alessio, E; Bregant, F; Ceschia, V; Mestroni, G; Pacor, S; Sava, G1

Other Studies

11 other study(ies) available for ruthenium and Carcinoma

ArticleYear
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
    International journal of molecular sciences, 2022, Apr-29, Volume: 23, Issue:9

    Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cisplatin; Coordination Complexes; Drug Resistance, Neoplasm; Female; Histones; Humans; Ligands; Molecular Structure; Organometallic Compounds; Osmium; Ovarian Neoplasms; Ruthenium

2022
[Ru(η
    Dalton transactions (Cambridge, England : 2003), 2022, May-31, Volume: 51, Issue:21

    Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Carcinoma; Cell Line, Tumor; Chemistry, Pharmaceutical; Coordination Complexes; Cymenes; Humans; Oxyquinoline; Ruthenium; Tissue Distribution; Zebrafish

2022
Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents.
    Journal of inorganic biochemistry, 2022, Volume: 237

    Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Coordination Complexes; Humans; Ligands; Male; Phenanthrolines; Reactive Oxygen Species; Ruthenium

2022
In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.
    Journal of inorganic biochemistry, 2010, Volume: 104, Issue:1

    Topics: Animals; Breast Neoplasms; Carcinoma; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Matrix Metalloproteinases; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Organometallic Compounds; Osmium; Ruthenium

2010
CARCINOMA OF THE LUNG IN RATS EXPOSED TO THE BETA-RADIATION OF INTRABRONCHIAL RUTHENIUM PELLETS. I. DOSERESPONSE RELATIONSHIPS.
    Journal of the National Cancer Institute, 1963, Volume: 31

    Topics: Animals; Carcinoma; Lung Neoplasms; Mice; Neoplasms; Neoplasms, Radiation-Induced; Research; Ruthenium

1963
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.
    Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:2

    Topics: Apoptosis; Carcinoma; Colorectal Neoplasms; Humans; Indazoles; Mitochondria; Organometallic Compounds; Ruthenium; Salts; Tumor Cells, Cultured

2005
Treatment of residual metastases with Na[trans-RuCl4 (DMSO)lm] and ruthenium uptake by tumor cells.
    Anti-cancer drugs, 1996, Volume: 7, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm, Residual; Organometallic Compounds; Ruthenium; Survival Analysis

1996
Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex.
    Clinical & experimental metastasis, 1998, Volume: 16, Issue:4

    Topics: Animals; Antineoplastic Agents; Carcinoma; Dimethyl Sulfoxide; Female; Flow Cytometry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Ruthenium

1998
Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines.
    Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 3

    Topics: Carcinoma; Colonic Neoplasms; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Interferon-alpha; Interferon-beta; Interferon-gamma; Interferons; Ruthenium; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1992
Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats.
    Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:3

    Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma; Colorectal Neoplasms; Dose-Response Relationship, Drug; Imidazoles; Indazoles; Male; Organometallic Compounds; Rats; Rats, Inbred Strains; Ruthenium

1992
Antineoplastic effect of mer-trichlorobisdimethylsulphoxideaminorutheniumIII against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4].
    Chemico-biological interactions, 1991, Volume: 78, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma; Cisplatin; Imidazoles; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Organometallic Compounds; Ruthenium; Survival Analysis

1991